Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.
about
The challenge of developmental therapeutics for adrenocortical carcinomaCOP9 signalosome subunit 6 (CSN6) regulates E6AP/UBE3A in cervical cancer.5th International ACC Symposium: Future and Current Therapeutic Trials in Adrenocortical Carcinoma.Dual inhibition of Akt and c-Met as a second-line therapy following acquired resistance to sorafenib in hepatocellular carcinoma cells.HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis
P2860
Hepatocyte Growth Factor/cMET Pathway Activation Enhances Cancer Hallmarks in Adrenocortical Carcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hepatocyte Growth Factor/cMET ...... s in Adrenocortical Carcinoma.
@ast
Hepatocyte Growth Factor/cMET ...... s in Adrenocortical Carcinoma.
@en
type
label
Hepatocyte Growth Factor/cMET ...... s in Adrenocortical Carcinoma.
@ast
Hepatocyte Growth Factor/cMET ...... s in Adrenocortical Carcinoma.
@en
prefLabel
Hepatocyte Growth Factor/cMET ...... s in Adrenocortical Carcinoma.
@ast
Hepatocyte Growth Factor/cMET ...... s in Adrenocortical Carcinoma.
@en
P2093
P2860
P50
P1433
P1476
Hepatocyte Growth Factor/cMET ...... ks in Adrenocortical Carcinoma
@en
P2093
Camilo Jimenez
Christopher G Wood
Gilbert J Cote
Guermarie Velazquez-Torres
Kanishka Sircar
Lance Pagliaro
Levent Ozsari
Liem M Phan
Maria Angelica Cortez
Roeland Verhaak
P2860
P304
P356
10.1158/0008-5472.CAN-14-3707
P407
P577
2015-08-17T00:00:00Z